Vimarsana
Biggest News Aggregation in the World

Page 4 - Use Authorisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Authorisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Authorisation Today - Breaking & Trending Today

Dotz confirms US$2.3m orders on track - Media Releases - Vimarsana News

Dotz confirms US$2.3m orders on track - Media Releases

Dotz Nano (ASX:DTZ) shares increased 5 per cent today after an activity update to the ASX outlining two purchase orders for US$2.3 million for its SARS-CoV-2 virus detection technology and multi-country distribution agreements to be delivered in the next two years.

Has SAGE finally got it right? Covid infections are ALREADY flatlining in England - Vimarsana News

Has SAGE finally got it right? Covid infections are ALREADY flatlining in England

Data from the Government's Covid dashboard suggest the latest surge in infections peaked last Thursday, when there were just over 44,000 in a day.

Africa seeks more Covid-19 vaccine doses from India - Vimarsana News

Africa seeks more Covid-19 vaccine doses from India

India was a key vaccine exporter to Africa before it stopped the exportation to focus on fighting the local infections.

Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India - Vimarsana News

Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India

Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India

Cipla seeks govt help on pricing, customs ahead of paying $1 billion advance for Moderna vaccine - Vimarsana News

Cipla seeks govt help on pricing, customs ahead of paying $1 billion advance for Moderna vaccine

Cipla is in advanced talks with Moderna to bring its single-dose Covid-19 vaccine to India and has appealed to the Centre to ease the process with prices, customs duty and other protocols.